Platinum Investment Management LTD Leap Therapeutics, Inc. Transaction History

Platinum Investment Management LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$0.29 - $0.72 $308,426 - $765,748	-1,063,539 Reduced 80.09%	264,413 $89,000
Q3 2021 Nov 09, 2021	BUY	$1.35 - $4.01 $564,171 - $1.68 Million	417,905 Added 45.92%	1,327,952 $5.33 Million
Q1 2021 May 13, 2021	SELL	$1.82 - $3.01 $282,485 - $467,188	-155,212 Reduced 14.57%	910,047 $1.73 Million
Q4 2020 Feb 12, 2021	BUY	$1.49 - $2.37 $960,734 - $1.53 Million	644,788 Added 153.35%	1,065,259 $2.4 Million
Q3 2020 Nov 13, 2020	BUY	$1.68 - $2.17 $706,391 - $912,422	420,471 New	420,471 $833,000

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $239M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Platinum Investment Management LTD with notifications on news.